| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 05:00:02 UTC |
|---|
| Update Date | 2022-11-30 19:26:15 UTC |
|---|
| HMDB ID | HMDB0115548 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) |
|---|
| Description | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of eicosadienoic acid at the C-1 position and one chain of arachidonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCC\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC InChI=1S/C43H73O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-42(44)49-39-41(40-50-52(46,47)48)51-43(45)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h11-14,17-20,24,26,30,32,41H,3-10,15-16,21-23,25,27-29,31,33-40H2,1-2H3,(H2,46,47,48)/b13-11-,14-12-,19-17-,20-18-,26-24-,32-30-/t41-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-eicosadienoyl-2-arachidonoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-eicosadienoyl-2-arachidonoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(20:2/20:4) | SMPDB, HMDB | | PA(20:2n6/20:4n6) | SMPDB, HMDB | | PA(20:2w6/20:4w6) | SMPDB, HMDB | | PA(40:6) | SMPDB, HMDB | | Phosphatidic acid(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) | SMPDB, HMDB | | Phosphatidic acid(20:2/20:4) | SMPDB, HMDB | | Phosphatidic acid(20:2n6/20:4n6) | SMPDB, HMDB | | Phosphatidic acid(20:2w6/20:4w6) | SMPDB, HMDB | | Phosphatidic acid(40:6) | SMPDB, HMDB | | Phosphatidate(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) | SMPDB, HMDB | | Phosphatidate(20:2/20:4) | SMPDB, HMDB | | Phosphatidate(20:2n6/20:4n6) | SMPDB, HMDB | | Phosphatidate(20:2w6/20:4w6) | SMPDB, HMDB | | Phosphatidate(40:6) | SMPDB, HMDB | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) | SMPDB |
|
|---|
| Chemical Formula | C43H73O8P |
|---|
| Average Molecular Weight | 749.023 |
|---|
| Monoisotopic Molecular Weight | 748.504306309 |
|---|
| IUPAC Name | [(2R)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCC\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC |
|---|
| InChI Identifier | InChI=1S/C43H73O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-42(44)49-39-41(40-50-52(46,47)48)51-43(45)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h11-14,17-20,24,26,30,32,41H,3-10,15-16,21-23,25,27-29,31,33-40H2,1-2H3,(H2,46,47,48)/b13-11-,14-12-,19-17-,20-18-,26-24-,32-30-/t41-/m1/s1 |
|---|
| InChI Key | HYIBQGMLYWBSKK-AFCCIHQDSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0076513)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0076521)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z)) (PathBank: SMP0076524)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0091789)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0067767)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0067772)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0067773)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0067775)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)) (PathBank: SMP0076518)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0076516)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/24:0) (PathBank: SMP0076523)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0076517)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0034712)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0034713)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)) (PathBank: SMP0034714)
- De Novo Triacylglycerol Biosynthesis TG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0034715)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 5.7 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 38.4186 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.92 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5486.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 547.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 356.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 334.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1266.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 2065.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1164.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 227.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3926.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1308.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 3018.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1478.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 788.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 449.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 910.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) | [H][C@@](COC(=O)CCCCCCCCC\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC | 5397.1 | Standard polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) | [H][C@@](COC(=O)CCCCCCCCC\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC | 4603.0 | Standard non polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) | [H][C@@](COC(=O)CCCCCCCCC\C=C/C\C=C/CCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC | 5314.9 | Semi standard non polar | 33892256 |
Derivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)O[Si](C)(C)C | 5340.6 | Semi standard non polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)O[Si](C)(C)C | 4703.8 | Standard non polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)O[Si](C)(C)C | 5489.8 | Standard polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 5319.9 | Semi standard non polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4670.8 | Standard non polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4819.9 | Standard polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5555.6 | Semi standard non polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4811.0 | Standard non polar | 33892256 | | PA(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5493.9 | Standard polar | 33892256 |
|
|---|